Hyderabad-based pharmaceutical company Granules India and the National Institute of Pharmaceutical Education and Research (NIPER) in Mohali, Chandigarh have announced the signing of a Memorandum of Understanding (MoU) to establish Dr Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical Development (CCE-ISPD). 

This pioneering initiative aims to bring sustainability and innovation at the core of pharmaceutical research and development. The centre will focus on crucial areas such as exploring plant-based excipients, advancements in polymer-free pharmaceutical formulations, innovative methods in producing directly compressible crystals, promotion of solvent-free pharmaceutical processes, and the development of resource-efficient and energy-efficient pharmaceutical products.

The collaboration will feature joint research initiatives, ensuring a seamless flow of knowledge between the industry and academia. Granules India has committed support for the establishment and continuous operation of the research centre.

The partnership includes the establishment of state-of-the-art laboratories and research facilities within the NIPER campus to facilitate comprehensive research for the development of sustainable and innovation-driven pharmaceuticals. This partnership marks a significant stride in accentuating sustainability within the pharmaceutical domain, promising transformative changes for the industry and society at large globally.